Tetraspanin CD151 mediates communication between prostate cancer cells and osteoblasts
Invasion and migration of cancer cells are crucial for the formation of secondary lesions. These require activation of signalling cascades modulated by number of regulatory molecules. One such molecule is CD151, a member of evolutionary conserved tetraspanin family. CD151 is involved in cell adhesion, motility and cancer progression due to formation of complexes with laminin-binding integrins and regulation of growth factor receptors function (e.g. HGFR, TGFβR, EGFR). Recent studies point to correlation between CD151 expression and high tumour grade in prostate cancer (PCa). Herein, we investigated a possible role of CD151 in communication between cancer cells and either cancer-associated fibroblasts (CAFs) or osteoblasts, an interplay which is significant for metastasis. The analysis showed that although CAFs strongly enhanced both migration and invasion of PC3 prostate cancer cells, the effect was not dependent on CD151. On the other hand, CD151 was found to promote 3D migration as well as invasive growth in response to osteoblasts-secreted growth factors. Obtained data revealed that knockdown of CD151 abolished activation of pro-migratory/pro-survival kinases (i.e FAK, Src, HSP27) triggered by osteoblasts, along with expression of matrix metalloproteinase-13. These suggest that CD151 participate in communication between PCa cells and bone microenvironment and the process can be considered as a significant step of PCa progression and metastasis.
Ang J, Fang B-L, Ashman LK and Frauman AG (2010) The migration and invasion of human prostate cancer cell lines involves CD151 expression. Oncology Reports 24: 10.3892/or_00001022
Ang J, Lijovic M, Ashman LK, Kan K and Frauman AG (2004) CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator? Cancer Epidemiol Biomarkers Prev 13: 1717-1721.
Baldwin G, Novitskaya V, Sadej R, Pochec E, Litynska A, Hartmann C, Williams J, Ashman L, Eble JA and Berditchevski F (2008) Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin. J Biol Chem 283: 35445-35454. 10.1074/jbc.M806394200
Baldwin LA, Hoff JT, Lefringhouse J, Zhang M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, van Nagell JR, Wang C, Chen L, Plattner R, Kaetzel DM, Luo J, Lu M, West D, Liu C, Ueland FR, Drapkin R, Zhou BP and Yang XH (2014) CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling. Oncotarget 5: 12203-12217.
Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC and Mihatsch MJ (2000) Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31: 578-583.
Chien CW, Lin SC, Lai YY, Lin BW, Lee JC and Tsai SJ (2008) Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer. Clin Cancer Res 14: 8043-8051. 10.1158/1078-0432.CCR-08-1651
Collette L, Burzykowski T and Schröder FH (2006) Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials. Eur J Cancer 42: 1344-1350. 10.1016/j.ejca.2006.02.011
Copeland BT, Bowman MJ and Ashman LK (2013) Genetic ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate cancer in the TRAMP model. Mol Cancer Res 11: 95-105. 10.1158/1541-7786.MCR-12-0468
Detchokul S, Newell B, Williams ED and Frauman AG (2014) CD151 is associated with prostate cancer cell invasion and lymphangiogenesis in vivo. Oncol Rep 31: 241-247. 10.3892/or.2013.2823
Festuccia C, Bologna M, Gravina GL, Guerra F, Angelucci A, Villanova I, Millimaggi D and Teti A (1999) Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int J Cancer 81: 395-403.
Franco M, Muratori C, Corso S, Tenaglia E, Bertotti A, Capparuccia L, Trusolino L, Comoglio PM and Tamagnone L (2010) The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth. J Biol Chem 285: 38756-38764. M110.145417 [pii]
Garin-Chesa P, Old LJ and Rettig WJ (1990) Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A 87: 7235-7239.
Hall CL, Bafico A, Dai J, Aaronson SA and Keller ET (2005) Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 65: 7554-7560. 10.1158/0008-5472.CAN-05-1317
Hashida H, Takabayashi A, Tokuhara T, Hattori N, Taki T, Hasegawa H, Satoh S, Kobayashi N, Yamaoka Y and Miyake M (2003) Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer 89: 158-167. 10.1038/sj.bjc.6601015
Hong IK, Jin YJ, Byun HJ, Jeoung DI, Kim YM and Lee H (2006) Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J Biol Chem 281: 24279-24292. M601209200 [pii]
Hornebeck W, Emonard H, Monboisse JC and Bellon G (2002) Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 12: 231-241.
Huang XY, Ke AW, Shi GM, Ding ZB, Devbhandari RP, Gu FM, Li QL, Dai Z, Zhou J and Fan J (2010) Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer 116: 5440-5451. 10.1002/cncr.25485
Kazarov AR, Yang X, Stipp CS, Sehgal B and Hemler ME (2002) An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology. J Cell Biol 158: 1299-1309.
Klosek SK, Nakashiro K, Hara S, Goda H, Hasegawa H and Hamakawa H (2009) CD151 regulates HGF-stimulated morphogenesis of human breast cancer cells. Biochem Biophys Res Commun 379: 1097-1100. S0006-291X(09)00034-5 [pii]
Klosek SK, Nakashiro K, Hara S, Shintani S, Hasegawa H and Hamakawa H (2005) CD151 forms a functional complex with c-Met in human salivary gland cancer cells. Biochemical and Biophysical Research Communications 336: 10.1016/j.bbrc.2005.08.106
Kohno M, Hasegawa H, Miyake M, Yamamoto T and Fujita S (2002) CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 97: 336-343. 10.1002/ijc.1605 [pii]
Kwon MJ, Park S, Choi JY, Oh E, Kim YJ, Park YH, Cho EY, Nam SJ, Im YH, Shin YK and Choi YL (2012) Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. Br J Cancer 106: 923-930. 10.1038/bjc.2012.11
Lee D, Suh YL, Park TI, Do IG, Seol HJ, Nam DH and Kim ST (2013) Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas. J Surg Oncol 107: 646-652. 10.1002/jso.23249
Logothetis CJ and Lin SH (2005) Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5: 21-28. 10.1038/nrc1528
Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ and Cher ML (1999) Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 59: 1987-1993.
Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD and Cunha GR (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011.
Reichert JC, Quent VM, Burke LJ, Stansfield SH, Clements JA and Hutmacher DW (2010) Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment. Biomaterials 31: 7928-7936. 10.1016/j.biomaterials.2010.06.055
Romanska HM, Potemski P, Krakowska M, Mieszkowska M, Chaudhri S, Kordek R, Kubiak R, Speirs V, Hanby AM, Sadej R and Berditchevski F (2015a) Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers. Br J Cancer 113: 1350-1357. 10.1038/bjc.2015.344
Romanska HM, Potemski P, Kusinska R, Kopczynski J, Sadej R and Kordek R (2015b) Expression of CD151/Tspan24 and integrin alpha 3 complex in aid of prognostication of HER2-negative high-grade ductal carcinoma in situ. Int J Clin Exp Pathol 8: 9471-9478.
Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350: 1655-1664. 10.1056/NEJMra030831
Sadej R, Grudowska A, Turczyk L, Kordek R and Romanska HM (2014) CD151 in cancer progression and metastasis: a complex scenario. Lab Invest 94: 41-51. 10.1038/labinvest.2013.136
Sadej R, Romanska H, Baldwin G, Gkirtzimanaki K, Novitskaya V, Filer AD, Krcova Z, Kusinska R, Ehrmann J, Buckley CD, Kordek R, Potemski P, Eliopoulos AG, Lalani e-N and Berditchevski F (2009) CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol Cancer Res 7: 787-798. 10.1158/1541-7786.MCR-08-0574
Sadej R, Romanska H, Kavanagh D, Baldwin G, Takahashi T, Kalia N and Berditchevski F (2010) Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res 70: 6059-6070. 10.1158/0008-5472.CAN-09-3497
Sieh S, Lubik AA, Clements JA, Nelson CC and Hutmacher DW (2010) Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model. Organogenesis 6: 181-188.
Sterk LM, Geuijen CA, van den Berg JG, Claessen N, Weening JJ and Sonnenberg A (2002) Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo. J Cell Sci 115: 1161-1173.
Sugiura T and Berditchevski F (1999) Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J Cell Biol 146: 1375-1389.
Testa JE, Brooks PC, Lin JM and Quigley JP (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59: 3812-3820.
Tokuhara T, Hasegawa H, Hattori N, Ishida H, Taki T, Tachibana S, Sasaki S and Miyake M (2001) Clinical significance of CD151 gene expression in non-small cell lung cancer. Clinical Cancer Research 7:
Yanez-Mo M, Barreiro O, Gonzalo P, Batista A, Megias D, Genis L, Sachs N, Sala-Valdes M, Alonso MA, Montoya MC, Sonnenberg A, Arroyo AG and Sanchez-Madrid F (2008) MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells. Blood 112: 10.1182/blood-2008-02-139394
Yang W, Li P, Lin J, Zuo H, Zuo P, Zou Y and Liu Z (2012) CD151 promotes proliferation and migration of PC3 cells via the formation of CD151-integrin α3/α6 complex. J Huazhong Univ Sci Technolog Med Sci 32: 383-388. 10.1007/s11596-012-0066-y
Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, Kazarov AR, Andzelm MM, Strominger JL, Brown M and Hemler ME (2008) CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res 68: 3204-3213. 68/9/3204 [pii]
Yauch RL, Berditchevski F, Harler MB, Reichner J and Hemler ME (1998) Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration. Mol Biol Cell 9: 2751-2765.
Yue S, Mu W and Zöller M (2013) Tspan8 and CD151 promote metastasis by distinct mechanisms. Eur J Cancer 49: 2934-2948. 10.1016/j.ejca.2013.03.032
Zhu GH, Huang C, Qiu ZJ, Liu J, Zhang ZH, Zhao N, Feng ZZ and Lv XH (2011) Expression and prognostic significance of CD151, c-Met, and integrin alpha3/alpha6 in pancreatic ductal adenocarcinoma. Dig Dis Sci 56: 1090-1098. 10.1007/s10620-010-1416-x
Acta Biochimica Polonica is an open access quarterly and publishes four issues a year. All contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made, ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. There are no additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Copyright for all published papers © stays with the authors.
Copyright for the journal: © Polish Biochemical Society.